title: Uncertainty in assessing impact of drug-drug interactions on oxycodone metabolite patterns.
authors.affiliation: Aegis Sciences Corporation, Nashville, TN, USA Department of Clinical Pharmacy, University of Tennessee, Memphis, TN, USA anne.depriest@aegislabs.com.
authors.forename: Anne Z
authors.initials: AZ
authors.lastname: DePriest
authors.affiliation: Aegis Sciences Corporation, Nashville, TN, USA Department of Clinical Pharmacy, University of Tennessee, Memphis, TN, USA.
authors.forename: Brandi L
authors.initials: BL
authors.lastname: Puet
authors.affiliation: Aegis Sciences Corporation, Nashville, TN, USA.
authors.forename: Rebecca
authors.initials: R
authors.lastname: Heltsley
authors.affiliation: Aegis Sciences Corporation, Nashville, TN, USA.
authors.forename: Timothy
authors.initials: T
authors.lastname: Robert
authors.affiliation: Aegis Sciences Corporation, Nashville, TN, USA Vanderbilt University, Department of Pathology, Immunology, and Microbiology, Nashville, TN, USA.
authors.forename: David L
authors.initials: DL
authors.lastname: Black
mesh_terms: D000701:Analgesics, Opioid / Q000652:urine*; D005260:Female; D006801:Humans; D008297:Male; D009019:Morphinans / Q000652:urine*; D010098:Oxycodone / Q000652:urine*; D010111:Oxymorphone / Q000652:urine*; D010146:Pain / Q000188:drug therapy*
chemical_list: D000701:Analgesics, Opioid; D009019:Morphinans; D010111:Oxymorphone; D010098:Oxycodone